Garadacimab
Garadacimab is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including ANDEMBRY. Available dosage form: injection, solution.
Drug Details
- Generic Name
- Garadacimab
- Brand Names
- ANDEMBRY
- Application Number
- BLA761367
- Sponsor
- CSL
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- GARADACIMAB
Indications and Usage
1 INDICATIONS AND USAGE ANDEMBRY is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. ANDEMBRY is an activated Factor XII (FXIIa) inhibitor (monoclonal antibody) indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. ( 1 )